Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Thalidomide
Revenue, means the sales value of Thalidomide
This report studies sales (consumption) of Thalidomide in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Thalidomide in each application, can be divided into
Application 1
Application 2
Application 3
United States Thalidomide Market Report 2016
1 Thalidomide Overview
1.1 Product Overview and Scope of Thalidomide
1.2 Classification of Thalidomide
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Thalidomide
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Thalidomide (2011-2021)
1.4.1 USA Thalidomide Sales and Growth Rate (2011-2021)
1.4.2 USA Thalidomide Revenue and Growth Rate (2011-2021)
2 USA Thalidomide Competition by Manufacturers
2.1 USA Thalidomide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Thalidomide Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Thalidomide Average Price by Manufactures (2015 and 2016)
2.4 Thalidomide Market Competitive Situation and Trends
2.4.1 Thalidomide Market Concentration Rate
2.4.2 Thalidomide Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Thalidomide Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Thalidomide Sales and Market Share by Type (2011-2016)
3.2 USA Thalidomide Revenue and Market Share by Type (2011-2016)
3.3 USA Thalidomide Price by Type (2011-2016)
3.4 USA Thalidomide Sales Growth Rate by Type (2011-2016)
4 USA Thalidomide Sales (Volume) by Application (2011-2016)
4.1 USA Thalidomide Sales and Market Share by Application (2011-2016)
4.2 USA Thalidomide Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Thalidomide Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Thalidomide Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Allergan
5.2.2 Thalidomide Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Allergan Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Alnylam Pharmaceuticals
5.3.2 Thalidomide Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Alnylam Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Amgen
5.4.2 Thalidomide Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Amgen Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Angstrom Pharmaceuticals
5.5.2 Thalidomide Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Angstrom Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Acceleron Pharma
5.6.2 Thalidomide Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Acceleron Pharma Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biocon
5.7.2 Thalidomide Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biocon Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bionomics
5.8.2 Thalidomide Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bionomics Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 CASI Pharmaceuticals
5.9.2 Thalidomide Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 CASI Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Celgene Corporation
5.10.2 Thalidomide Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Celgene Corporation Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Enzon Pharmaceuticals
5.12 Five Prime Therapeutics
5.13 Fujifilm Kyowa Kirin Biologics
5.14 Genentech
5.15 Genexine
5.16 Hetero Drugs
5.17 ImClone Systems
5.18 Intas Pharmaceuticals
5.19 Kyowa Hakko Kirin
5.20 Levolta Pharmaceuticals
5.21 Mabtech
5.22 Marsala Biotech
5.23 Neumedicines
5.24 Novartis
5.25 Oncobiologics
5.26 Onyx Pharmaceuticals
6 Thalidomide Manufacturing Cost Analysis
6.1 Thalidomide Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Thalidomide
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Thalidomide Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Thalidomide Market Forecast (2016-2021)
10.1 USA Thalidomide Sales, Revenue Forecast (2016-2021)
10.2 USA Thalidomide Sales Forecast by Type (2016-2021)
10.3 USA Thalidomide Sales Forecast by Application (2016-2021)
10.4 Thalidomide Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Thalidomide
Table Classification of Thalidomide
Figure USA Sales Market Share of Thalidomide by Type in 2015
Table Application of Thalidomide
Figure USA Sales Market Share of Thalidomide by Application in 2015
Figure USA Thalidomide Sales and Growth Rate (2011-2021)
Figure USA Thalidomide Revenue and Growth Rate (2011-2021)
Table USA Thalidomide Sales of Key Manufacturers (2015 and 2016)
Table USA Thalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thalidomide Sales Share by Manufacturers
Figure 2016 Thalidomide Sales Share by Manufacturers
Table USA Thalidomide Revenue by Manufacturers (2015 and 2016)
Table USA Thalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Thalidomide Revenue Share by Manufacturers
Table 2016 USA Thalidomide Revenue Share by Manufacturers
Table USA Market Thalidomide Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Thalidomide Average Price of Key Manufacturers in 2015
Figure Thalidomide Market Share of Top 3 Manufacturers
Figure Thalidomide Market Share of Top 5 Manufacturers
Table USA Thalidomide Sales by Type (2011-2016)
Table USA Thalidomide Sales Share by Type (2011-2016)
Figure USA Thalidomide Sales Market Share by Type in 2015
Table USA Thalidomide Revenue and Market Share by Type (2011-2016)
Table USA Thalidomide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Thalidomide by Type (2011-2016)
Table USA Thalidomide Price by Type (2011-2016)
Figure USA Thalidomide Sales Growth Rate by Type (2011-2016)
Table USA Thalidomide Sales by Application (2011-2016)
Table USA Thalidomide Sales Market Share by Application (2011-2016)
Figure USA Thalidomide Sales Market Share by Application in 2015
Table USA Thalidomide Sales Growth Rate by Application (2011-2016)
Figure USA Thalidomide Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Thalidomide Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Thalidomide Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Thalidomide Sales Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angstrom Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Thalidomide Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Thalidomide Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Thalidomide Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Thalidomide Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Therapeutics Thalidomide Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Thalidomide Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Thalidomide Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Thalidomide Sales Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Drugs Thalidomide Sales Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImClone Systems Thalidomide Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Thalidomide Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Thalidomide Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Thalidomide Sales Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neumedicines Thalidomide Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Thalidomide Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Thalidomide Sales Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Pharmaceuticals Thalidomide Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Manufacturers in 2015
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure USA Thalidomide Production and Growth Rate Forecast (2016-2021)
Figure USA Thalidomide Revenue and Growth Rate Forecast (2016-2021)
Table USA Thalidomide Production Forecast by Type (2016-2021)
Table USA Thalidomide Consumption Forecast by Application (2016-2021)
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...